NIHR Maudsley BRC Blog

Our latest news and events

Could intranasal oxytocin be used to treat people at clinically high risk of psychosis?

Oxytocin, a hormone most often associated with childbirth, is also known for its effects on social-emotional cognition and behaviour. According to new research supported by the NIHR Maudsley BRC, oxytocin also alters blood flow in the hippocampus — a brain region strongly implicated in the onset of psychosis — in those at clinically high risk of psychosis.

By NIHR Maudsley BRC at 12 Feb 2019
Read more >

CRIS blog: Mother’s improved clinical outcomes correlate with improvements in mother-infant interactions in an MBU

Alastair Macdonald is Emeritus Professor of Clinical Outcomes Research at the Institute of Psychiatry, Psychology and Neuroscience at King's College London.

Lucy Stephenson is Clinical Research Associate, Mental Health and Justice Project at the Institute of Psychiatry, Psychology and Neuroscience at King's College London.

 

By NIHR Maudsley BRC at 3 Sep 2018
Read more >

CRIS blog: Inpatient use and area-level socio-environmental factors in people with psychosis

Dr Margaret Heslin is a research fellow and honorary lecturer in King’s Health Economics at the Institute of Psychiatry, Psychology & Neuroscience at King's College London.

By NIHR Maudsley BRC at 13 Jun 2018
Read more >

Cannabidiol (CBD) could represent a ‘new class of treatment’ for psychosis

A constituent of cannabis could hold promise as a new class of treatment for psychosis, according to King’s College London research showing significant benefits in a clinical trial.

By NIHR Maudsley BRC at 14 Dec 2017
Read more >

Brain stimulation may improve cognitive performance in people with schizophrenia

Brain stimulation could be used to treat cognitive deficits frequently associated with schizophrenia, according to a new study supported by the NIHR Maudsley Biomedical Research Centre (BRC).

By NIHR Maudsley BRC at 25 Jul 2017
Read more >